'Single use only': obfuscation or the necessary attainment of zero risk?
Published online: 17 November 1997
"Single use only": obfuscation or the necessary attainment of zero risk?
Stringent reuse of medical devices could save us millions of dollars each year
MJA 1997; 167: 519-520
Readers may print a single copy for personal use. No further reproduction or distribution of the articles should proceed without the permission of the publisher. For permission, contact the Australasian Medical Publishing Company
Journalists are welcome to write news stories based on what they read here, but should acknowledge their source as "an article published on the Internet by The Medical Journal of Australia <http://www.mja.com.au/MJA/>".
Make a comment - - ©MJA1997
|
The revolution in plastics technology over the past 40 years has
resulted in a wide variety of healthcare items produced as
presterilised "single use only" disposables. In spite of the
admonitions of many peak and government organisations in Australia
and overseas,1-3 many
hospitals are reprocessing single-use medical devices because
staff feel this will result in substantial monetary savings.4 The labelling as "single use only" of
non-critical items used exclusively on external body surfaces (as
opposed to critical items used invasively), commented on by Stewart
in this issue of the Journal, is an extremely
relevant issue in the debate. Here, we argue that the global term
"single use" provides a barrier to rational analysis by masking the
complexity of the issues and the range of devices.
Is a "single use only" item truly disposable, or is it a durable item that has been labelled "single use only" by the manufacturer according to certain criteria? Such criteria may include cost, life expectancy, potential physical or infection hazards after repeated use, minimisation of the manufacturer's legal liability, or even an expression of lack of confidence in the capability of hospitals to reprocess the item satisfactorily.
| |
| Manufacturers would probably argue forcefully that all single-use labelling is appropriate | Manufacturers would probably argue forcefully that all single-use labelling is appropriate, including that of non-critical items. Legal advice to many hospitals confirms the need to comply with manufacturers' instructions and thus precludes reprocessing. Nevertheless, infection control prin ciples suggest that, where an item of equipment is used externally against unbroken skin and does not penetrate a sterile site, thorough cleaning between uses is all that is required, and sterility is certainly not essential. Whether the reprocessing of such items is cost-effective may be questioned. However, if reuse of single-use, non-critical medical devices were prohibited by law, then logic demands that restaurants provide "single use only" crockery and cutlery to each patron -- as these items enter body cavities and are regularly contaminated with body fluids, they induce as much, if not more, risk of transmitting infection. Stewart advocates legislation to prohibit inappropriate labelling. As sensible as this suggestion appears, Australia constitutes less than 1% of the world market for single-use products, and overseas manufacturers are unlikely to change their labelling to meet requirements unique to our country. Reprocessing of "single use only" instruments that penetrate sterile body sites is an even more contentious issue. The recent National Health and Medical Research Council (NHMRC) expert report,5 which examined reuse of critical items, confirmed the economic rationality of reprocessing some "single use only" items by stating that if such reuse was not permitted in Australia "either appropriate resources (estimated at $100 million per annum) to purchase sufficient single use devices must be provided or a reduction in services be explicitly recognised". However, the NHMRC panel also concluded that "continuation of the current practice of re-use cannot be condoned", and suggested that either Australian health ministers make a decision to disallow reuse of medical devices labelled as "single use only", or allow reuse to continue but that it be subject to more stringent regulations.
|
|
Although State and Commonwealth departments of health do not support
reuse,6-8 the dilemma for
many hospitals continues because they implicitly recognise that it
is in their interests for services to continue without the imperative
to obtain increased funding to purchase further stocks of single-use
equipment. Therefore, reprocessing, although against written
policy, is tolerated by governments.
From the patient's perspective, there is both an expectation and a legal right to be assured that any equipment used is devoid of infection risk, as well as being non-toxic, non-pyrogenic, physicochemically stable and functionally reliable. To what extent does the healthcare consumer require this assurance? The outcome in the recent Sydney case of patient-to-patient transmission of HIV9 suggests that the judiciary, presumably reflecting a community view, believes that zero risk should be the accepted standard. By this precedent, any reprocessing of "single use only" items is likely to be unacceptable to the community, in spite of scientific argument to the contrary and the economic implications of such a decision. No one who has seriously considered this issue could deny that a policy on the reprocessing of critical items marked as "single use only" will be difficult to formulate, or that prospective and scientifically rigorous data on their potential transmission hazards are urgently needed. In response to the NHMRC document, the Australian Health Ministers Advisory Council (AHMAC) has commissioned detailed studies into the risk of disease transmission by cardiac electrophysiology catheters and their ability to be satisfactorily reprocessed (Dr H Wellington, Chair, NHMRC working party on re-use of medical devices labelled as single use, personal communication). The alternatives provided by the NHMRC expert panel represent two diametrically opposed solutions to the problem. To continue disposing of all items labelled as "single use only", regardless of their ability to be adequately re-processed, creates unnecessary expense at a time when healthcare dollars are scarce. To agree to the reprocessing of certain items may lead to opposition, particularly from manufacturers. Nevertheless, if, after expert advice, the community and its parliamentary representatives can agree on an acceptable, practical and economically attainable level of risk, then appropriate characterisation of those devices suitable for reprocessing under stringent conditions could save Australia's healthcare system millions of dollars each year. While acknowledging that it is a challenging question, it is one that Australia's health ministers must consider, and one on which they must develop and disseminate a collective view. We hope that the relevant issues will continue to be debated by AHMAC. R Michael Whitby
David F M Looke
|
<URL: http://www.mja.com.au/>
© 1997 Medical Journal of Australia.
We appreciate
your comments.
Shifting focus to adolescent wellbeing and inclusive participation in the digital age
Allyson R Todd, Elena Wang, Stephanie R Partridge
The clinical presentation, investigation, and management of women diagnosed with endometriosis in Australian general practices, 2011–2021: an open cohort study
Danielle Mazza, Kailash Thapaliya, Sharinne B Crawford, Alissia Hui, Maryam Moradi, Luke E Grzeskowiak
The impact of the Breast Screen NSW transition from film to digital mammography, 2002–2016: a linked population health data analysis
Rachel Farber, Nehmat Houssami, Katy J L Bell
Non‐technical errors associated with deaths in surgical care, Australia, 2012–2019, by surgical specialty (Australian and New Zealand Audit of Surgical Mortality): a retrospective cohort study
Jesse Ey, Victoria Kollias, Octavia Lee, Kelly Hou, Matheesha Herath, John B North, Ellie Treloar, Suzanne Edwards, Martin Bruening, Adam J Wells, Guy J Maddern
The CURE Asthma roadmap
Gary P Anderson, Anthony Flynn, Phil G Bardin, John D Blakey, Shyamali C Dharmage, Paul Foster, Peter G Gibson, Adam Jaffe, Alan James, Christine R Jenkins, Sundram Sivamalai, Peter D Sly, Guy B Marks, Vanessa M McDonald, Judy Wetttenhall
Evidence from Australian cohort studies about asthma trajectories and transitions across the life course: a narrative review
Caroline Lodge, Xin Dai, Ingrid A. Laing, Michael P Menden, Anthony Flynn, Gary P Anderson, Sarath Ranganathan, Shyamali C Dharmage